BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 40 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 4,895.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $214,000 | -73.2% | 56,821 | -67.3% | 0.01% | -76.2% |
| Q4 2020 | $799,000 | -28.1% | 173,683 | +65.8% | 0.02% | -55.3% |
| Q2 2020 | $1,112,000 | +108.2% | 104,782 | -11.6% | 0.05% | +74.1% |
| Q1 2020 | $534,000 | +330.6% | 118,533 | +307.7% | 0.03% | +440.0% |
| Q4 2019 | $124,000 | -10.1% | 29,077 | -21.3% | 0.01% | -28.6% |
| Q3 2019 | $138,000 | – | 36,961 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABNER HERRMAN & BROCK LLC | 239,000 | $2,679,000 | 0.48% |
| EAM Investors, LLC | 81,854 | $918,000 | 0.20% |
| CFO4Life Group, LLC | 12,003 | $135,000 | 0.05% |
| Phoenix Holdings Ltd. | 104,782 | $1,112,000 | 0.05% |
| WINTON GROUP Ltd | 118,487 | $1,328,000 | 0.03% |
| Merit Financial Group, LLC | 28,731 | $322,000 | 0.03% |
| HighPoint Advisor Group LLC | 13,533 | $151,000 | 0.03% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 23,000 | $258,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 52,216 | $579,000 | 0.02% |
| IHT Wealth Management, LLC | 13,000 | $146,000 | 0.02% |